This is according to a survey conducted by a niche group for the 2009 Biomed week
A survey by the "Nisha" group, which deals with placement in the fields of technology, conducted especially for the "Biomed 2009" week, reveals that at the same time as a decrease of 30% - 40% in the first quarter of 2009, in the number of jobs offered in the life sciences industry, compared to the corresponding period last year, there are still a number These positions are difficult to fill, and among them are particularly notable for their lack of experienced CEOs. "Experienced CEOs are a commodity It's rare, says Lizzie Shub London, co-director of 'Nisha Biotech'. "In the field of biotechnology, it is not possible to find CEOs who have made an exit, or an IPO, simply because there were almost none in Israel and also in the medical device market there are very few senior candidates who have made exits and are available. to look for a new job". More wanted: engineers, VPs and quality managers, system engineers and experienced senior and junior development managers."
Regarding the salary, the survey reveals that in most of the biomed companies, and along the entire length of the line, the salary decreased by about 10%, in almost all areas, except for the quality assurance area. When it comes to recruiting new personnel, there is a difference between the field of biotechnology and the field of medical equipment (which in 2008 was relatively good): "In the field of biotechnology there is almost no recruitment and the supply of excellent candidates is large. The field is in crisis and for many people the only option to engage in the profession in which they chose to specialize is by dropping In the field of medical devices, many companies tend to think that the recession will bring them experienced and high-quality candidates at a lower salary than they are used to. But, the reality is different. In most cases, these companies are disappointed. The supply of job seekers, especially in the medical equipment market, is relatively small and most of the job seekers are not willing to compromise on salary."
And another interesting fact that came up during the survey: a diagnosis of a 'leakage' of manpower from the biomed field to the clinictech field: "The clinictech field, which is very multidisciplinary in nature, allows candidates to move into the field, the need for candidates from the field of mechanics (specializing in thermodynamics), and electrical engineers, so that engineers who are expelled from the market Medical professionals find positions quite easily in the growing cleantech market."
11 תגובות
"A notable lack of experienced CEOs"
The disadvantage stems from Israel's unique policy of not hiring workers over a certain age
There is no shortage of experienced CEOs (emphasis on experienced), there is a shortage because they are looking for an "experienced" CEO with 30 years of experience but under 40
And if they find it, then they offer insulting conditions...
Giora
An experienced CEO beyond his years
straw man:
Point referred to write in the article and I quote:
"In the field of biotechnology, it is not possible to find CEOs who have reached an exit, or an IPO, simply because there were almost none in Israel, and also in the medical device market there are very few senior candidates who have exited and are available to look for a new position."
We are talking here about the success of companies. Such success - what to do? - measured in money.
It turns out, therefore, that at least Lizzy London again thinks that the companies established in the field have failed.
"Usually there is no work because there is no demand in the market for failures.
For example, they have been working on a cure for cancer for 40 years and in the meantime they have raised a straw."
What nonsense, it's just a lie.
Studies dealing with cancer have revealed a wide array of cellular control mechanisms whose failure causes cancer.
One good example of an achievement in the field is the vaccine against the virus, infection with which greatly increases the chance of getting cervical cancer (the advertisement for the vaccine was broadcast until recently).
It turns out that cancer is too general a name for a phenomenon caused by hundreds of failures of cellular control.
I don't think there will be such a thing as a "cure for cancer" it's kind of like saying there will be a cure for a virus.
And that's just the little I know.
light:
I'm the last one to defend the government's disregard for education, but that's not what we're talking about here.
It's about experts running away because they don't have a job in the industry.
The academy trains experts but it should not be the only place where they are employed!
The problem described here is a problem of lack of successful entrepreneurs among the experts who left the academy.
I'm sorry to say this again:
But we have become a state of ghost creatures of the metastases of the German brain, which took over the world, greedy for money, minds against nature and the way of the earth, without respect and the memory of our essence and duties.
With great regret.
So get off!
: Idle ambitions do not serve us at all, but on the contrary: they humiliate us in the eyes of the nations, our name, our duties and our true destiny.
Michael,
The government that is supposed to be responsible for the field of higher education in Israel is elevated in its position and smuggles the brains. Those who cut academic staff standards and do not invest in research, should not be surprised that the researchers and academics leave the country.
My people, the cry is not about the 'brain drain' but about the 'brain industry'.
A vision of 'Israel' to keep the 'heart' for the sake of all others.
Usually there is no work because there is no demand in the market for failures.
For example, they have been working on a cure for cancer for 40 years and in the meantime they have raised a straw.
Ami:
Who exactly is smuggling?
no job.
They smuggle us abroad and then cry that there is a brain drain.
No brain drain! There is exploitation of Israeli minds elsewhere.
These Israeli minds are not given expression in Israel anyway.
Too bad. Investing many years of studies and research to discover that there is no work in Israel in the field.